Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
RW1963 schreef op 24 maart 2021 17:33 :
[...]
I hope so, het is genoeg geweest.
De andere aandelen die jij noemt heb ik ook. Dus hopelijk heb jij succes dan heb ik het ook. De laatste tijd zijn geen prettige tijden. Voor Affimed wil ik een uitzondering maken.
Istie weer hoor. Hoe smaakt dat bekertje azijn in de morgen? Misachien ook eens nemen
Nel ASA: Signs MoU with Haldor Topsoe for delivery of end-to-end green ammonia and methanol solutions (Oslo, 25 March 2021) Nel ASA (Nel, OSE:NEL) has entered into an MoU with Haldor Topsoe with the intent to offer customers end-to-end green ammonia and methanol solutions, based on globally leading technologies from the two companies. "We are very excited to join forces with Haldor Topsoe for possible future development of end-to-end green ammonia and green methanol solutions to customers, both which are widely regarded as important carbon free fuels and energy carriers for the future. This is a market that is expected to grow significantly in the years to come and we look forward to working with Haldor Topsoe to deliver complete solutions to customers, based on demonstrated technologies available today” says Jon André Løkke, CEO of Nel ASA. Under the MoU, Nel will bring extensive experience within alkaline and PEM electrolysis technology and proprietary hardware, as well as system engineering for the hydrogen production. Haldor Topsoe will supply engineering, proprietary hardware, catalyst and technical service for its ammonia and methanol technologies. “We are very pleased to take the next step in our excellent relation with Nel. Together, we can offer end-to-end renewable electricity to green ammonia and green methanol solutions based on the most reliable technologies available today. Driven by our vision to be recognized as the global leader in carbon emission reduction technologies by 2024, we are excited to offer innovative and attractive low-carbon solutions to our customers. This cooperation speaks directly to our customers’ needs as we see massive interest from the market requesting basic engineering, license, and process guarantee in one package,” says Amy Hebert, Chief Commercial Officer of Haldor Topsoe. The MoU is a non-exclusive agreement that will serve as a basis for further development of a collaboration agreement which is expected to complete later this year.
Nel ASA: Annual Report and Sustainability Report 2020 (Oslo, 25 March 2021) Nel ASA (Nel, OSE:NEL) has published its Annual report and Sustainability report for 2020. This is the first Sustainability Report published by Nel, in accordance with GRI Standards, supplemented by considerations found in TCFD and Euronext guidelines. The reports are attached to this stock exchange notice and published on www.nelhydrogen.com. Veel nieuws in de mail vandaag Generale meeting 2021 is ook midden april! 14 of 16 dacht ik. Groene dag?
Sjaak90 schreef op 25 maart 2021 07:12 :
[...]
Istie weer hoor. Hoe smaakt dat bekertje azijn in de morgen? Misachien ook eens nemen
Alles goed met jou vriend ;-)
2020 Highlights• Revenue and other operating income increased by 14 % from 2019 to 2020, despite being negatively impacted by global travel restrictions and extraordinary measures related to the Covid-19 pandemic which have impacted progress on customer/partner dialogue, order intake, installation, commissioning, and production efficiency.• Record-high order backlog at end of 2020 of NOK 981.1 million, up 91 % from 2019.• Year-end cash balance of NOK 2 332.9 million (2019: 526.0).• Signed framework agreement with Lhyfe for delivery of up to 60 MW of alkaline electrolysers in France. The framework agreement follows an NOK 10 million purchase order for an alkaline electrolyser• Received purchase order from Nikola Corporation, with a value of more than NOK 280 million, for 85 MW alkaline electrolysers related to the deployment of the world’s first 8 ton/day hydrogen fueling stations.• Received purchase order for 20 MW alkaline electrolyser from Everfuel A/S for the green hydrogen production facility adjacent to the Frederica refinery in Denmark with a value of about NOK 75 million.• Received several purchase orders for PEM electrolyser stacks for the U.S. Navy, bringing total booked orders from this customer with a value of more than NOK 85 million in 2020.• Selected as preferred supplier and signed a memorandum of understanding (MoU) with Iberdrola for a 20 MW PEM solution for a green fertilizer project in Spain. The hydrogen plant is scheduled to commence operations in 2021.• Awarded a NOK 38 million grant by the US Department of Energy (DOE) for development of advanced components and manufacturing methods to enable low-cost hydrogen from electrolysis.• Received purchase order for multiple H2Station™ units from Iwatani Corporation of America with a value of more than NOK 150 million.• Received purchase order from Hydrogen Energy Network Co., Ltd. (HyNet) for three additional H2Station® hydrogen fueling stations in South Korea with a value of about NOK 42 million.• Completed successful private placements and subsequent offering, raising NOK 2 383.3 million in gross proceeds. SUBSEQUENT EVENTS• On January 14, 2021, following the MoU signed in 2020, Iberdrola issued a purchase order for 20 MW PEM electrolyser for the green fertilizer project in Spain with a value of NOK 140 million.• On January 21, 2021, Nel launched a target for producing green hydrogen at 1.5 USD/kg target by 2025, to outcompete fossil alternatives, on its first ever Capital Markets Day.• On February 24, 2021, a private placement of 49.5 million new shares was completed, at a price per share of NOK 24.75, raising NOK 1 225.1 million in gross proceeds.KEY FIGURESKEY FIGURES202020192018Revenue and operating income651.9569.7489.0Total operating expenses1 066.4823.3685.1EBITDA-251.5-178.1-131.6Operating loss-414.5-253.6-196.1Pre-tax income (loss)1 245.5-277.2-197.5Net income (loss)1 261.9-269.7-188.8Net cash flow from operating activities-215.9-199.7-142.8Cash balance end of period2 332.9526.0349.7Report from the Board of DirectorsNel ASA I Annual report 20209
Financial developmentIncome statementNel reported revenue and operating income in 2020 of NOK 651.9 million, up 14.4 % from NOK 569.7 million in 2019. The growth can mainly be attributed to Nel Hydrogen Fueling’s revenue increasing 30%. Fueling constituted 48% of Nel’s total revenue in 2020, up from 43% in 2019. At the end of 2020, Nel had a record-high order backlog of approximately NOK 981 million, up 87% from NOK 526 million in 2019. The backlog only includes firm purchase orders with agreed price, volume, timing and terms and conditions.Raw materials expenses totalled NOK 394.0 million (342.4), an increase of 15.1% from 2019. The increased raw materials are related to the 11.4 % increase in revenue from contracts with customers and is also affected by increased costs from project execution in the Fueling and Electrolyser divisions. Personnel expenses amounted to NOK 329.4 million (243.2), the 37.4 % increase compared to 2019 is explained by a higher number of employees, up from 310 employees by the end of 2019 to 393 at the end of 2020. Other operating expenses amounted to NOK 180.0 million (162.2). The high level of personnel and other operating costs are the results of Nel’s strategic decision to pursue growth and higher activity levels. Costs for the share option program, which are included in personnel expenses, were NOK 8.6 million in 2020 compared to 10.3 million in 2019.EBITDA ended at NOK -251.5 million (-178.1), negatively impacted by ramp up costs. Nel’s customer projects often include new geography, customer segments, technological components and/or products leading to additional costs and risk.Depreciation, amortisation and impairment increased to NOK 163.0 million (75.5), mainly driven by impairment of intangible assets of NOK 58.9 million (NOK 38.0 mill in RotoLyzer® technology and NOK 20.9 million in other technology development in Electrolyser Norway where we no longer expect to complete the development).The operating loss amounted to NOK -414.5 million (-253.6).Net financial items amounted to a gain of NOK 1 660.0 million (-23.6) and were driven by a positive fair value adjustment of shareholdings in Everfuel and Nikola, with NOK 1 531.8 million (a value of NOK 125.00 per share as of December 31, 2020) and NOK 100.2 million (a value of USD 15.26 per share as of December 31, 2020), respectively. Pre-tax income totalled NOK 1 245.5 million (-277.2) and the net income for the year was NOK 1 261.9 million, compared to a loss of NOK -269.7 million in 2019.Financial positionTotal assets were NOK 6 136.7 million at the end of 2020, compared to NOK 2 430.7 million at the end of 2019. Total equity was NOK 5 468.3 million. Thus, the equity ratio was 89 percent.Cash flowNet cash flow from operating activities in 2020 was NOK -215.9 million, compared to NOK -199.7 million in 2019. The development is mainly due to higher personnel expenses driven by increase in full time employees. Net cash flow from investing activities was NOK -294.4 million (-134.1). Nel has purchased property, plant and equipment for NOK 148.5 (49.9) million in 2020, mainly related to the expansion at Herøya, Norway, in the electrolyser division.Nel’s cash balance at the end of 2020 was NOK 2 332.9 million. The increase from end of 2019 is mainly due to raising net proceeds of NOK 818.8 million and NOK 1 265.5 million from the share capital increase in January and June, respectively. This is partly offset by negative cash flow from operations and investments.10Report from the Board of Directors
SegmentsNEL HYDROGEN ELECTROLYSERFinancial reviewAmounts in NOK million20202019Revenue and operating income337.53 2 7. 4EBITDA-84.2- 4 7. 7Total assets1 256.31 108.1Number of employees179148Revenue and operating income increased by 3 % from 2019. Revenue from Norway increased by 36 % due to higher sales of alkaline electrolysers and recognition of NOK 18.7 million in grants related to the RotoLyzer® technology. Increased revenue from Norway is offset by 5 % decreased revenue from US and its related PEM electrolysers. Nel Hydrogen Electrolyser has been particularly negatively impacted by the general business slow down and delay in closing orders resulting from Covid-19.EBITDA was NOK -84.2 million in 2020, positively impacted by NOK 18.7 million amortisation of received technology development grants, but overall a decrease from NOK -47.7 million in 2019. The reduction of NOK 36.5 million was mainly due to ramp-up costs and slightly lower margins in Norway and US as well as a general negative impact on operations due to Covid-19.Total assets have increased by 13 % from 2019, which is mainly related to investments in the new manufacturing facility at Herøya, Norway, and increased inventories.Headcount in Nel Hydrogen Electrolyser has increased from 148 employees by the end of 2019 to 179 at the end of 2020, driven by an increase in project and production personnel.DEVELOPMENT AND KEY PROJECTSLarge purchase order from Nikola CorporationIn June 2020, Nel Hydrogen Inc., a wholly owned subsidiary of Nel ASA, received a purchase order (“PO”) from Nikola Corporation (Nikola) for 85 MW alkaline electrolysers related to the deployment of the world’s first 8 ton/day hydrogen fueling stations. The PO has a value in excess of NOK 280 million and is included in the company’s order backlog. The joint development program of the fueling station continues, but the process and implementation has been delayed by strategy reviews and other Covid-19 related factors incl. severe travel restrictions. Green production facility in DenmarkNel received purchase order for 20 MW electrolyser with Everfuel A/S for the green hydrogen production facility adjacent to the Frederica refinery in Denmark with a value of NOK 75 million.Grant awarded to develop a novel electrolyser stackNel has been awarded a NOK 38 million grant by the US Department of Energy (DOE) for development of advanced components and manufacturing methods to enable low-cost hydrogen from electrolysis.Framework agreement with LhyfeNel has entered into a framework agreement for the delivery of up to 60 MW of electrolysers to Lhyfe Labs SAS (Lhyfe) in France.The framework agreement follows a NOK 10 million purchase order for an A150 alkaline electrolyser in March 2020, which will be used to produce green hydrogen for a fleet of buses in Bouin, France. The agreement covers 20 additional electrolysers, equal to around 60 MW, intended to be purchased over the next 4 years under similar terms and conditions.New manufacturing facility, Herøya, NorwayNel is expanding electrolyser production to accommodate large-scale projects by constructing a fully automated manufacturing facility at Herøya, Norway. This factory will represent the first industrial-scale production of the most efficient electrolysers on the market, at a game-changing low cost. The amount of expenditures recognised in the carrying amount for Herøya expansion in the course of construction is NOK 114.0 (13.8) million as of 31 December 2020. Total contractual commitments beyond 2020 for the acquisition of physical components related to the Herøya expansion in the Electrolyser division are NOK 171.6 million. The manufacturing facility is scheduled to have its test phase during Q2 2021 and ramp up phase in Q3 2021
Sjaak90 schreef op 25 maart 2021 07:12 :
[...]
Istie weer hoor. Hoe smaakt dat bekertje azijn in de morgen? Misachien ook eens nemen
Sjaak90 24 december 2020 10:30 Fijne dagen allemaal. Met een GAK dit jaar van 8nok mag ik zeker niet klagen. Op naar de 50 Ik hoop dat uiteraard ook vriend ;-)
Heb je ook een samenvatting ??
Nou, ik heb de aandelen in Duitsland, lekker naar beneden. Hoera....
Zullen we maar weer een muziekje opzetten. Koersdoel NOK 40 blijft staan voor mij dus wees geduldig en je hebt geen verlies wanneer je wacht. Hoop ik :-)
Cosy schreef op 25 maart 2021 12:13 :
Heb je ook een samenvatting ??
Heb je er zelf al naar gekeken? Laat ik er een paar cijfers uitpakken, waarbij ik 2020 afzet tegen 2019. De omzet is met 14% gestegen, maar het operationeel verlies is ook met 63% opgelopen. Het nettoverlies is omgeslagen naar een winst van NOK 1.3 miljard en dat komt doordat het aandeel van NEL in Everfuel meer waard is geworden, voor een kleiner bedrag geldt hetzelfde bij Nikola. Voor de operatie geven de kasstromen een wat beter beeld. Daar kun je zien dat de operationele kasstromen nog altijd negatief zijn, maar dat dit met 8% is opgelopen. Ondertussen is er 120% meer geld naar investeringen gegaan. Met een omzetstijging van 14% ziet die 8% meer negatief uit de operatie er al iets beter uit dan die 63%. Dat komt doordat in het resultaat het begrip operatie ruimer wordt opgevat. Bij de kasstromen zie je (zoals gebruikelijk) een mooie splitsing tussen operatie, investeringen en financiering. Daarom is het altijd goed om dit overzicht er ook even bij te pakken. De cijfers moet je natuurlijk afzetten tegen de verwachting van de markt en in hoeverre dat al zat verwerkt in de prijs. Je hoeft je niet te laten intimideren door lijvige rapporten. Wat ik hier doe, kun je ook toepassen bij andere bedrijven. Natuurlijk, als je dit aan 10 mensen vraagt krijg je 10 meningen. Succes.
Hele duidelijke visie en er van uitgaande dat waterstof veel gebruikt gaat worden zitten wij er goed bij.
en dan is de nieuwe fabriek nog niet operationeel. Nel kan concurreren.
NEL, de huidige dagkoers droomde we een jaar geleden van ;-)
RW1963 schreef op 24 maart 2021 17:33 :
[...]
I hope so, het is genoeg geweest.
De andere aandelen die jij noemt heb ik ook. Dus hopelijk heb jij succes dan heb ik het ook. De laatste tijd zijn geen prettige tijden. Voor Affimed wil ik een uitzondering maken.
@RW1963, misschien moet jij maar eens stoppen met beleggen. Je jankt de hele boel bij elkaar als het even tegen zit. Zet je geld op een spaarrekening. Dat geeft je rust.
4finance schreef op 25 maart 2021 17:38 :
[...]
@RW1963, misschien moet jij maar eens stoppen met beleggen. Je jankt de hele boel bij elkaar als het even tegen zit. Zet je geld op een spaarrekening. Dat geeft je rust.
Amen. Ik heb alle gekochte aandelen NEL nog steeds! Janken? Nee hoor, wel af en toe teleurgesteld.
Uiteraard vind ik mij zelf een flink tikketje dom dat ik net als vorig jaar eind Jan begin Feb niet alles verkocht heb ( op Enbridge na maar dit is mijn dividendaandeel) om later een heleboel %tjes lager terug te kopen. De grafieken gaven heel duidelijk aan dat er een berg lucht in de koers zat maar als ik nu naar de 5 jaargrafiek kijk maak ik mij niet heel druk. Helaas vind ik mijzelf niet kansloos om onder de 21 kronen te kopen bij een emissie. We zullen wel zien. Goed weekend
* Nel ASA : Barclays initiates coverage with overweight rating; target price NOK 40.5 * Nel ASA : Barclays starts with overweight rating; price target NOK 40.5 EUROPE RESEARCH ROUNDUP Bron: Reuters
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee